Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages

PLGA-based EVG nanoformulation increased the intracellular uptake of EVG, as well as enhanced viral suppression in HIV-infected macrophages, suggesting its potential for improved HIV treatment in monocytic cells.